Literature DB >> 32334941

Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers?

Anne Mayeur1, Naouel Ahdad2, Laetitia Hesters1, Michael Grynberg3, Serge Romana4, Charlotte Sonigo5, Nelly Frydman6.   

Abstract

RESEARCH QUESTION: Chromosomal translocations are known genetic causes of premature ovarian insufficiency syndrome. Are certain translocations associated with decreased capacity of small antral follicles to respond to exogenous FSH? Does the prognosis after preimplantation genetic testing for structural rearrangements differ in couples with female or male translocation carriers and according to the type of translocation?
DESIGN: A single-centre, retrospective, observational study covering a 10-year period. One hundred and thirty-nine females carrying a translocation were compared with 192 partners of male translocation carriers. To evaluate ovarian response to FSH, the follicular output rate was used, defined by ratio between the pre-ovulatory follicle count on day of HCG x 100/antral follicle count (AFC). To determine a cut-off of metaphase II oocytes and biopsied embryos as predictor of obtaining a balanced embryo transfer, receiver operator characteristic curves were plotted. RESULT: A decreased capacity of small antral follicles to respond to exogenous FSH in female translocation carriers was found. The number of metaphase II oocytes in both groups was weakly informative as a predictor of obtaining an embryo transfer. The number of biopsied embryos had some clinical value, however, and allowed a cut-off of 6.5 to be determined for female translocation carriers versus 5.5 for the partners of male translocation carriers. Live birth rates, however, were not different between female and male translocations carriers.
CONCLUSIONS: Female translocation carriers may respond poorly to ovarian stimulation, and present a higher rate of unbalanced embryos, which means that higher gonadotrophin doses may be required to increase the number of biopsied embryos.
Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromosomal translocation; Controlled ovarian stimulation; FORT; PGT-outcomes

Mesh:

Year:  2020        PMID: 32334941     DOI: 10.1016/j.rbmo.2020.01.025

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  Are ovarian responses and the number of transferable embryos different in females and partners of male balanced translocation carriers?

Authors:  Mingyue Liu; Zhiqin Bu; Yan Liu; Jinhao Liu; Shanjun Dai
Journal:  J Assist Reprod Genet       Date:  2022-08-04       Impact factor: 3.357

2.  Age and Serum AMH and FSH Levels as Predictors of the Number of Oocytes Retrieved from Chromosomal Translocation Carriers after Controlled Ovarian Hyperstimulation: Applicability and Limitations.

Authors:  Yulia V Shilenkova; Anna A Pendina; Irina D Mekina; Olga A Efimova; Evgeniia M Komarova; Elena A Lesik; Mariia A Ishchuk; Elena M Fedorova; Olga G Chiryaeva; Lubov' I Petrova; Vera S Dudkina; Olga E Talantova; Alexander M Gzgzyan; Igor Yu Kogan
Journal:  Genes (Basel)       Date:  2020-12-25       Impact factor: 4.096

3.  In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing.

Authors:  Chantal B Bartels; Reeva Makhijani; Prachi Godiwala; Alison Bartolucci; John C Nulsen; Daniel R Grow; Lawrence Engmann; Claudio A Benadiva
Journal:  F S Rep       Date:  2020-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.